Research Summary
mRNA (messenger RNA) cancer vaccines and therapeutics represent a groundbreaking approach to cancer treatment and prevention. These innovative therapies use synthetic mRNA molecules to instruct the patient's own cells to produce specific proteins or antigens that stimulate the immune system to recognize and target cancer cells. mRNA cancer vaccines can be tailored to an individual's unique cancer profile, making them a promising avenue for personalized cancer treatment. By training the immune system to recognize and attack cancer cells, these vaccines hold the potential to provide effective, targeted, and less invasive treatment options. Additionally, mRNA technology has gained prominence for its role in the development of COVID-19 vaccines, underscoring its versatility and transformative potential in the field of medicine and disease prevention.
According to DIResearch's in-depth investigation and research, the global mRNA Cancer Vaccines and Therapeutics market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of mRNA Cancer Vaccines and Therapeutics include Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA, Ethris, Tiba Biotechnology etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of mRNA Cancer Vaccines and Therapeutics. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global mRNA Cancer Vaccines and Therapeutics market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the mRNA Cancer Vaccines and Therapeutics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of mRNA Cancer Vaccines and Therapeutics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of mRNA Cancer Vaccines and Therapeutics Include:
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
mRNA Cancer Vaccines and Therapeutics Product Segment Include:
Vaccines
Therapeutics
mRNA Cancer Vaccines and Therapeutics Product Application Include:
Adenocarcinoma
Mucinous Carcinoma
Adenosquamous Carcinoma
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global mRNA Cancer Vaccines and Therapeutics Industry PESTEL Analysis
Chapter 3: Global mRNA Cancer Vaccines and Therapeutics Industry Porter's Five Forces Analysis
Chapter 4: Global mRNA Cancer Vaccines and Therapeutics Major Regional Market Size and Forecast Analysis
Chapter 5: Global mRNA Cancer Vaccines and Therapeutics Market Size and Forecast by Type and Application Analysis
Chapter 6: North America mRNA Cancer Vaccines and Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe mRNA Cancer Vaccines and Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China mRNA Cancer Vaccines and Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) mRNA Cancer Vaccines and Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America mRNA Cancer Vaccines and Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa mRNA Cancer Vaccines and Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global mRNA Cancer Vaccines and Therapeutics Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 mRNA Cancer Vaccines and Therapeutics Market Overview 1.1 Product Definition and Statistical Scope 1.2 mRNA Cancer Vaccines and Therapeutics Product by Type 1.2.1 Global mRNA Cancer Vaccines and Therapeutics Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 Vaccines 1.2.3 Therapeutics 1.3 mRNA Cancer Vaccines and Therapeutics Product by Application 1.3.1 Global mRNA Cancer Vaccines and Therapeutics Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Adenocarcinoma 1.3.3 Mucinous Carcinoma 1.3.4 Adenosquamous Carcinoma 1.3.5 Others 1.4 Global mRNA Cancer Vaccines and Therapeutics Market Revenue Analysis (2019-2030) 1.5 mRNA Cancer Vaccines and Therapeutics Market Development Status and Trends 1.5.1 mRNA Cancer Vaccines and Therapeutics Industry Development Status Analysis 1.5.2 mRNA Cancer Vaccines and Therapeutics Industry Development Trends Analysis 2 mRNA Cancer Vaccines and Therapeutics Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 mRNA Cancer Vaccines and Therapeutics Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global mRNA Cancer Vaccines and Therapeutics Market Analysis by Regions 4.1 mRNA Cancer Vaccines and Therapeutics Overall Market: 2023 VS 2024 VS 2030 4.2 Global mRNA Cancer Vaccines and Therapeutics Revenue and Forecast Analysis (2019-2030) 4.2.1 Global mRNA Cancer Vaccines and Therapeutics Revenue and Market Share by Region (2019-2024) 4.2.2 Global mRNA Cancer Vaccines and Therapeutics Revenue Forecast by Region (2025-2030) 5 Global mRNA Cancer Vaccines and Therapeutics Market Size by Type and Application 5.1 Global mRNA Cancer Vaccines and Therapeutics Market Size by Type 5.2 Global mRNA Cancer Vaccines and Therapeutics Market Size by Application 6 North America 6.1 North America mRNA Cancer Vaccines and Therapeutics Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America mRNA Cancer Vaccines and Therapeutics Market Size by Type 6.4 North America mRNA Cancer Vaccines and Therapeutics Market Size by Application 6.5 North America mRNA Cancer Vaccines and Therapeutics Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe mRNA Cancer Vaccines and Therapeutics Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Type 7.4 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Application 7.5 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China mRNA Cancer Vaccines and Therapeutics Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China mRNA Cancer Vaccines and Therapeutics Market Size by Type 8.4 China mRNA Cancer Vaccines and Therapeutics Market Size by Application 9 APAC (excl. China) 9.1 APAC (excl. China) mRNA Cancer Vaccines and Therapeutics Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) mRNA Cancer Vaccines and Therapeutics Market Size by Type 9.4 APAC (excl. China) mRNA Cancer Vaccines and Therapeutics Market Size by Application 9.5 APAC (excl. China) mRNA Cancer Vaccines and Therapeutics Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America mRNA Cancer Vaccines and Therapeutics Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Type 10.4 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Application 10.5 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Country 10.5.1 Mecixo 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Type 11.4 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Application 11.5 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Market Competition by Manufacturers 12.1 Global mRNA Cancer Vaccines and Therapeutics Market Revenue by Key Manufacturers (2020-2024) 12.2 mRNA Cancer Vaccines and Therapeutics Competitive Landscape Analysis and Market Dynamic 12.2.1 mRNA Cancer Vaccines and Therapeutics Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 Moderna Therapeutics 13.1.1 Moderna Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Product Portfolio 13.1.3 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.2 CureVac 13.2.1 CureVac Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 CureVac mRNA Cancer Vaccines and Therapeutics Product Portfolio 13.2.3 CureVac mRNA Cancer Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.3 Translate Bio 13.3.1 Translate Bio Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 Translate Bio mRNA Cancer Vaccines and Therapeutics Product Portfolio 13.3.3 Translate Bio mRNA Cancer Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.4 BioNTech 13.4.1 BioNTech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 BioNTech mRNA Cancer Vaccines and Therapeutics Product Portfolio 13.4.3 BioNTech mRNA Cancer Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.5 Sangamo Therapeutics 13.5.1 Sangamo Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Product Portfolio 13.5.3 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.6 Argos Therapeutics 13.6.1 Argos Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Product Portfolio 13.6.3 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.7 In-Cell-Art 13.7.1 In-Cell-Art Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.7.2 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Product Portfolio 13.7.3 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.8 eTheRNA 13.8.1 eTheRNA Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.8.2 eTheRNA mRNA Cancer Vaccines and Therapeutics Product Portfolio 13.8.3 eTheRNA mRNA Cancer Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.9 Ethris 13.9.1 Ethris Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.9.2 Ethris mRNA Cancer Vaccines and Therapeutics Product Portfolio 13.9.3 Ethris mRNA Cancer Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.10 Tiba Biotechnology 13.10.1 Tiba Biotechnology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.10.2 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Product Portfolio 13.10.3 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 mRNA Cancer Vaccines and Therapeutics Industry Chain Analysis 14.2 mRNA Cancer Vaccines and Therapeutics Industry Raw Material and Suppliers Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 mRNA Cancer Vaccines and Therapeutics Typical Downstream Customers 14.4 mRNA Cancer Vaccines and Therapeutics Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support